May 22, 2025 FDA to Rethink COVID Booster Formula FDA advisers to vote on whether 2025–2026 COVID vaccines should target JN.1 descendants like LP.8.1 amid rising uncertainty over dominant strains. Reuters
May 22, 2025 FDA Approves Mepolizumab for Eosinophilic COPD Nucala gains FDA approval to treat chronic obstructive pulmonary disease, expanding its use to patients with eosinophilic inflammation. Conexiant
May 22, 2025 Dual Inhaler Halves Mild Asthma Attacks in Trial As-needed albuterol-budesonide was superior to albuterol alone for mild, uncontrolled asthma in new trial. Conexiant
May 20, 2025 New COVID Shot: LP.8.1? FDA advisers to consider recommending COVID-19 vaccine for 2025-2026 season to target LP.8.1 subvariant. Reuters
May 20, 2025 No Trials, No Boosters, Says FDA FDA to require new clinical trials for COVID booster approval in healthy Americans under 65, limiting fall availability to high-risk groups. Reuters
May 19, 2025 Protein-Based COVID Vaccine Gains FDA Approval The FDA has approved the first recombinant protein-based, non-mRNA COVID-19 vaccine. Conexiant
May 19, 2025 Zyrtec and Xyzal: FDA Issues Withdrawal Syndrome Warning A new safety alert highlights the potential for severe itch following discontinuation of long-term cetirizine and levocetirizine use. Conexiant
May 19, 2025 Bacteria Eat, Exploit Plastic: Study A hospital-derived strain of Pseudomonas aeruginosa was found to degrade medical plastic, use it as food, and form stronger biofilms, revealing new risks for device-related infections. Conexiant
May 14, 2025 FDA OKs AbbVie's Targeted Lung Drug The FDA has approved AbbVie's Emrelis, a targeted therapy for advanced non-small cell lung cancer with high c-Met expression. Reuters